PET-CT Scanner Device Market Estimated to Hit USD 3.34 Billion By 2028
by Express Systems
Friday 25th of March 2022
The market size of the global PET-CT scanner device is expected to reach USD 3.34 billion by 2028 according to a new study by Polaris Market Research.
Demand for the digital device segment is expected to increase during the forecast period. The use of digital scanner equipment improves the patient experience while improving accuracy, reduces scanning time, and increases the availability of small lesions. November 2019, Canon Medical Systems USA, Inc. launches its Cartesion Prime PET-CT device program.
The digital device aims to bring personal attention with high quality images, increased sensitivity, and reduced scan time. The Cartesion Prime Digital PET-CT system is equipped with a SiPM PET detector and the Aquilion Prime SP CT Device to get efficient and advanced PET-CT images that provide improved workflow.
The fixed device segment dominated the global market by 2020. However, the demand for the mobile component is expected to grow during the forecast period. Part of the portable device is increasingly being used in small and medium-sized health facilities. Other benefits associated with the segment of the mobile device include reduced costs, shorter installation time, lower initial investment, and reduced patient mobility. Leading market players such as GE, Philips, Siemens offer a wide variety of PET-CT scanner mobile devices.
The oncology segment dominated the global market by 2020. This product is increasingly being used to diagnose various types of cancer such as Lymphoma, Melanoma, Lung Cancer, Breast Cancer, and head and neck cancer among others. The product uses a combination of PET and CT device scanners to provide a detailed image of the plant's location, size, and position.
PET-CT device scans enable physicians to diagnose and diagnose, prescribe treatment, and track treatment progress. The detailed information provided by the scanners allows oncologists to provide effective treatment by reducing the amount of exposure to healthy tissue radiation and by diagnosing previously undiagnosed cancerous tissue.
Part of the hospital dominated the global market by 2020. The increase in the incidence of cancer and heart disease is in line with government programs to provide improved health services to citizens supporting the growth of this category. The growing need to carry out diagnostic procedures for effective detection, increasing the number of older people, and rising costs of health care in developing countries, such as India, China, and Japan, are improving hospital admissions.
Some of the major market participants include General Electric Co., Mediso Ltd., Toshiba Corporation, Siemens AG, Positron Corporation, Shimadzu Corporation, Perkin Elmer Inc., Fujifilm Holdings, Koninklijke Philips NV, Carestream, ECHO-SON SA, Hitachi Ltd. , Fonar Corporation, Esaote SPA, and Yangzhou Kindsway Biotech Co. Ltd.